P2.06-16 YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1271
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.06-32 YB-1 - A Key Factor in Mesothelioma Aggressive Growth and Behaviour

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma

PLoS ONE
Multidisciplinary
2013English

P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Frontiers in Oncology
Cancer ResearchOncology
2019English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy